Advertisement

Amarantus Therapeutics, Inc. Company Profile

18:10 EDT 18th May 2013 | BioPortfolio

Amarantus Therapeutics, Inc. is a privately-held biotechnology company developing first-in-class disease–modifying treatments that address the underlying cause of cell death, known as apoptosis, associated with a wide range of diseases, including but not limited to, neurodegenerative and cardiovascular. The Company’s most advanced drug candidate, AMRS001, is a growth factor indicated for the treatment of Parkinson’s disease and Myocardial Infarction. Currently incubating at the Parkinson’s Institute, Amarantus Therapeutics is seeking to raise a $1 million investment as a bridge to a $15 million Series A that it will use to advance its lead programs in Parkinson’s and Myocardial Infarction into clinical development. www.amarantustherapeutics.com


News Articles [ 124 Associated News Articles listed on BioPortfolio]

RBCC, Amarantus to commercialise parkinson's diagnostic platform

Rainbow BioSciences, a biotech subsidiary of Rainbow Coral (RBCC), and Amarantus Biosciences have moved into the final stages of the terms to jointly move the Amarantus NuroPro Parkinson's diagnostic...

Amarantus pays $40K for Power3 Medical's IP assets

Power3 Medical Products has agreed to sell all of its intellectual property assets to Amarantus BioScience for $40,000.  -More- 

Rainbow, Amarantus report joint venture agreement for NuroPro Parkinson's diagnostic platform

Rainbow Coral Corp. biotech subsidiary Rainbow BioSciences and Amarantus Biosciences have moved into the final stages of the terms for a deal. The pending joint venture agreement will see the two enti...

‘Unlist us’ Amarantus asks Berlin-Bremen stock exchange

Sunnyvale, California-based Amarantus BioSciences, a biotech company developing treatments and diagnostics for Parkinson's disease and traumatic brain injury, has initiated legal action to get itself...

RBCC JV Target Amarantus Presents Parkinson's Therapeutic at CNS Summit

NOKOMIS, Fla.--(BUSINESS WIRE)--Nov 29, 2012 - As Rainbow Coral Corp. (OTCBB: RBCC) nears a new joint venture agreement to commercialize advances made by Amarantus BioSciences (OTCBB: AMBS), the compa...

Amarantus BioScience to Present at the 15th Annual BIO CEO & Investor Conference

SUNNYVALE, Calif. , Feb. 8, 2013 /- Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with the neuro...

Amarantus BioScience to Present at the 15th Annual BIO CEO & Investor Conference

SUNNYVALE, Calif., Feb. 8, 2013 /PRNewswire/ -- Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated wit...

Top Five Stocks - Tuesday Volume Watch: Tag Like Me Corp, Warp 9, Inc. Amarantus Biosciences, Inc. Fannie Mae, Pristine Solutions, Inc.

LONDON, November 6, 2012 /PRNewswire/ -- Club Issues Volume Trading Report: Tag Like Me Corp (OTC: TAGG),Warp 9 Inc (OTC: WNYN),Amarantus Biosciences (OTC: AMBS),Fannie Mae (OTC: FNMA),Pristine So...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [ 4 Associated Companies listed on BioPortfolio]

Amarantus BioSciences, Inc.

Amarantus BioSciences, Inc. is a California-based development-stage biotechnology company founded in January 2008. The Company has a focus on developing certain biologics surround...

Amarantus Therapeutics, Inc.

Amarantus Therapeutics, Inc. is a privately-held biotechnology company developing first-in-class disease–modifying treatments that address the underlying cause of cell death,...

Amarantus BioScience Holdings, Inc.

Amarantus is a development-stage biotechnology company founded in January 2008. The Company is focused on developing unique products and proprietary technologies for the potential...

Amarantus BioScience, Inc.

Amarantus BioScience, Inc. is a development-stage biotechnology company founded in January 2008. The Company has a focus on developing certain biologics surrounding the intellectu...

More Information about "Amarantus Therapeutics, Inc." on BioPortfolio

We have published hundreds of Amarantus Therapeutics, Inc. news stories on BioPortfolio along with dozens of Amarantus Therapeutics, Inc. Clinical Trials and PubMed Articles about Amarantus Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Amarantus Therapeutics, Inc. Companies in our database. You can also find out about relevant Amarantus Therapeutics, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement